scholarly journals Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics

2013 ◽  
Vol 2 (4) ◽  
pp. 293-308 ◽  
Author(s):  
G. K. Siberry ◽  
M. J. Abzug ◽  
S. Nachman ◽  
Keyword(s):  
Infectious Diseases ◽  
American Academy ◽  
Disease Control ◽  
Opportunistic Infections ◽  
National Institutes Of Health ◽  
Executive Summary ◽  
American Academy Of Pediatrics ◽  
Prevention And Treatment ◽  
Control And Prevention ◽  
Hiv Exposed

Recommended Childhood Immunization Schedule

PEDIATRICS ◽  
1996 ◽  
Vol 98 (1) ◽  
pp. 158-158 ◽  
Author(s):  
Keyword(s):  
Infectious Diseases ◽  
American Academy ◽  
Family Physicians ◽  
Immunization Schedule ◽  
Childhood Immunization ◽  
Package Inserts ◽  
American Academy Of Pediatrics ◽  
Control And Prevention ◽  
New Vaccines ◽  
Made In

The Recommended Childhood Immunization Schedule United States, July—December 1996 was developed by the Committee on Infectious Diseases of the American Academy of Pediatrics in collaboration with the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention, and the American Academy of Family Physicians. Since the Schedule was last published in January 1996, no new vaccines have been approved by the Food and Drug Administration and as of May 15, 1996, no changes had been made in Academy recommendations.1 If additional changes are made before the next publication in the January 1997 issue of Pediatrics, the membership will be informed through other channels. For detailed information on the use of vaccines, providers should refer to the l994 Red Book: Report of the Committee on Infectious Diseases,2 the ACIP General Recommendations on Immunization3 and the vaccine package inserts.

scholarly journals COVID-19 vaccination for pregnant women: strategies for enhanced coverage

2021 ◽  
Vol 33 (3) ◽  
pp. 539-540
Author(s):  
Jennifer Britto John ◽  
Vinoth Gnana Chellaiyan Devanbu ◽  
Vijayalakshmi Kandaswamy
Keyword(s):  
American Academy ◽  
Disease Control ◽  
Pregnant Women ◽  
Advisory Group ◽  
Inactivated Vaccine ◽  
American Academy Of Pediatrics ◽  
Technical Advisory Group ◽  
Control And Prevention ◽  
The Government ◽  
Restricted Use

Following the recommendations from the National Technical Advisory Group (NTAG) on Immunization, the Government of India approved three vaccines – an inactivated vaccine, Covaxin and two non-replicating vector-based vaccines, Covishield and Sputnik V for restricted use in an emergency for pregnant women.(1)The late approval of vaccination of pregnant women was due to a lack of evidence, because pregnant women were excluded from previous COVID vaccination trials. The restricted use of this vaccine recommended by NTAG also complies with the regulations of the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics. (2-4)

Sign in / Sign up

Export Citation Format

Share Document